STOCK TITAN

PetVivo (PETV) secures $1M plus $1.5M optional equity funding

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

PetVivo Holdings, Inc. entered into a Subscription Agreement to receive $1,000,000 of equity financing in exchange for 1,250,000 shares of restricted common stock. The company received an initial $400,000 on March 13, 2026 and expects the remaining $600,000 on or before April 15, 2026.

The investor also received a purchase option to invest an additional $1,500,000 for 1,875,000 restricted shares, anticipated on or before June 30, 2026, on the same terms. The transaction is a private offering to an accredited investor under Section 4(a)(2) and Regulation D, and the shares are restricted securities subject to Rule 144.

Positive

  • None.

Negative

  • None.

Insights

PetVivo secures up to $2.5M in private equity funding.

PetVivo arranged a private equity deal for an immediate $1,000,000 raise tied to 1,250,000 restricted shares, with staged funding: $400,000 already received and $600,000 expected by April 15, 2026. This provides near-term liquidity without using public markets.

The investor also holds an option to commit another $1,500,000 for 1,875,000 restricted shares on the same terms, anticipated by June 30, 2026. Because the shares are restricted under Rule 144 and issued under Section 4(a)(2) and Regulation D to an accredited investor, any resale is constrained by securities law, which can moderate immediate market impact.

Overall, this is a non-public capital raise that increases share count but strengthens the cash position. Actual dilution and market effects will depend on how the company deploys the proceeds and whether the investor exercises the additional funding option.

false 0001512922 0001512922 2026-03-16 2026-03-16 0001512922 us-gaap:CommonStockMember 2026-03-16 2026-03-16 0001512922 PETV:WarrantsMember 2026-03-16 2026-03-16 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

March 16, 2026

Date of Report (Date of earliest event reported)

 

PETVIVO HOLDINGS, INC.

(Exact name of registrant as specified in its charter)

 

Nevada   001-40715   99-0363559

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

5151 Edina Industrial Blvd.

Suite 575

Edina, Minnesota

  55439
(Address of principal executive offices)   (Zip Code)

 

(952) 405-6216

Registrant’s telephone number, including area code

 

Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock   PETV   OTCQX
Warrants   PETVW   OTCID

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 

 

 

Item 1.01 Entry into a Material Definitive Agreement.

 

To the extent required, the discussion of the Subscription Agreement set forth in Item 3.02 below is incorporated by reference into this Item 1.01.

 

Item 3.02 Unregistered Sales of Equity Securities.

 

On March 13, 2026, PetVivo Holdings, Inc., including its wholly-owned subsidiaries PetVivo Animal Health and PetVivo AI, Inc., (collectively the “Company”, “we” and “us”) entered into a Subscription Agreement to receive One Million Dollars ($1,000,000) of equity financing in exchange for One Million Two Hundred Fifty Thousand (1,250,000) shares of Restricted Common Stock of the Company (“Shares”) (the “Offering”). The Company initially received Four Hundred Thousand Dollars ($400,000) of the Offering proceeds on March 13, 2026, and is scheduled to receive the remaining Six Hundred Thousand Dollars on or before April 15, 2026. Furthermore, the investor received a purchase option to invest an additional One Million Five Hundred Thousand Dollars ($1,500,000) of equity financing in exchange for One Million Eight Hundred Seventy-Five Thousand shares of Restricted Common Stock of the Company pursuant to the same terms and conditions; this additional equity financing is anticipated to be received on or before June 30, 2026. The Offering was conducted pursuant to the exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933, as amended (“Securities Act”) and Regulation D promulgated thereunder. The investor entered into the subscription agreement (the “Subscription Agreement”) with the Company and represented in writing that he, she, or it is an “accredited investor” (as such term is defined in Rule 501(a) of Regulation D under the Securities Act) and acquired the securities for his, her or its own account for investment purposes and any subsequent transfer or sales of these securities will be in accordance with the Securities Act or exempt from registration under the Securities Act. The shares of Common Stock will be “restricted securities” under Rule 144 of the Securities Act, and certificates representing the foregoing will bear a Rule 144 restrictive legend.

 

The form of Subscription Agreement is filed as Exhibit 10.1 to this Current Report on Form 8-K, respectively, and the description in this Current Report on Form 8-K of terms of Subscription Agreement are qualified in their entirety by reference to such exhibits.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits.
10.1 Form of Subscription Agreement
104 Cover Page Interactive Data File (formatted as Inline XBRL)

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized

 

  PETVIVO HOLDINGS, INC.
     
Date: March 16, 2026 By: /s/ John Lai
  Name: John Lai
  Title: Chief Executive Officer

 

 

 

FAQ

What equity financing did PetVivo Holdings (PETV) announce in this 8-K?

PetVivo entered a Subscription Agreement for $1,000,000 of equity financing in exchange for 1,250,000 restricted common shares. The deal is a private placement with a single accredited investor under Section 4(a)(2) and Regulation D of the Securities Act.

How much cash has PetVivo (PETV) already received from this financing?

PetVivo has already received $400,000 from the $1,000,000 financing as of March 13, 2026. The company expects to receive the remaining $600,000 on or before April 15, 2026, providing staged near-term liquidity.

What additional investment option is included in PetVivo’s (PETV) Subscription Agreement?

The investor obtained an option to invest an additional $1,500,000 in PetVivo for 1,875,000 restricted shares. This additional equity financing is anticipated to be funded on or before June 30, 2026, on the same terms and conditions as the initial investment.

Are the new PetVivo (PETV) shares freely tradable after this transaction?

No. The new PetVivo shares are issued as restricted securities under Rule 144 of the Securities Act. Certificates will bear a restrictive legend, and any future transfers must comply with registration requirements or a valid exemption from registration.

Under which securities law exemptions is PetVivo (PETV) conducting this offering?

The equity offering is conducted under Section 4(a)(2) of the Securities Act and Regulation D. The investor represented in writing that they are an accredited investor and acquired the securities for investment purposes, subject to applicable resale restrictions.

What securities instrument governs PetVivo’s (PETV) new financing terms?

The financing terms are set out in a Subscription Agreement between PetVivo and the investor. A form of this Subscription Agreement is filed as Exhibit 10.1, and the 8-K description is qualified in its entirety by reference to that exhibit.

Filing Exhibits & Attachments

6 documents
Petvivo Hldgs Inc

OTC:PETV

View PETV Stock Overview

PETV Rankings

PETV Latest News

PETV Latest SEC Filings

PETV Stock Data

27.66M
17.45M
Medical Devices
Healthcare
Link
United States
Edina